0.230
0.00 (0.00%)
前收盘价格 | 0.230 |
收盘价格 | 0.230 |
成交量 | 2,000 |
市值 | 34,272,300 |
市盈率 (P/E TTM) | 23.00 |
价格/销量 (P/S) | 4.81 |
股市价格/股市净资产 (P/B) | 3.05 |
52周波幅 | |
股息率 (DY TTM) | 2.61% |
营业毛利率 | 37.97% |
营业利益率 (TTM) | 45.96% |
稀释每股收益 (EPS TTM) | 0.010 |
季度收入增长率 (YOY) | 39.70% |
季度盈利增长率 (YOY) | 565.00% |
总债务/股东权益 (D/E MRQ) | 0.69% |
流动比率 (MRQ) | 4.55 |
营业现金流 (OCF TTM) | 5.50 M |
杠杆自由现金流 (LFCF TTM) | 6.62 M |
资产报酬率 (ROA TTM) | 19.34% |
股东权益报酬率 (ROE TTM) | 30.89% |
市场趋势
短期 | 中期 | ||
行业 | Engineering & Construction (MY) | 看涨 | 混合的 |
Engineering & Construction (全球的) | 看涨 | 混合的 | |
股票 | NPS | - | - |
AIStockmoo 评分
分析师共识 | 2.0 |
内部交易活动 | NA |
价格波动 | -2.0 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 2.0 |
平均 | 0.50 |
Nova Pharma Solutions Bhd provides engineering solutions to the pharma and biotech industries, focusing on the design and building phase of pharmaceutical and biotechnology plants. Its reportable segments include Design fee, EPCC, Post Design, and Other support fees. Design fee segment which derives maximum revenue, comprises conceptual designs that include user requirement specification, capacity analysis, and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes as well as authorities’ compliance requirements. Geographically, the company generates a majority of its revenue from Malaysia and the rest from Taiwan, Thailand, and Indonesia. |
|
部门 | Industrials |
行业 | Engineering & Construction |
投资方式 | Small Growth |
内部持股比例 | 73.44% |
该时间范围内无数据。
该时间范围内无数据。
股息率 (DY TTM) | 2.61% |
1年平均股息收益率 | 2.61% |
预计下次股息支付 | Dec 2025 |
除息日 | 公告日期 | 支付日期 | 详情 |
---|---|---|---|
11 Dec 2024 | 25 Nov 2024 | 27 Dec 2024 | 0.006 现金 |
每年股息收益率
年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
---|---|---|---|
2024 | 0.006 | 1 | 2.61 |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合